본문영역
-
Device/ICT
VUNO introduces cardiac arrest risk monitoring device at critical care society’s meet
VUNO will exhibit its AI-powered cardiac arrest risk monitoring device, VUNO Med-DeepCARS, at the 44th Korean Society of Critical Care Medicine (KSCCM) Annual Congress-Acute and Cr...
Yang Hyeon-su
2024-04-24 4:01 PM
-
Hospital
This pediatrician found greatest reward in children’s laughs but the government...
"We are very sorry that we will be unable to be by your side."That's what the Department of Pediatric Nephrology professors at Seoul National University Hospital (SNUH) wrote in a ...
Kim Ju-yeon
2024-04-24 1:46 PM
-
Pharma
Darzalex’s reimbursement has been in limbo for 3 years. Will it be different this time?
Attention is drawn to whether the reimbursement criteria for the multiple myeloma drug Darzalex (daratumumab), unchanged since May 2021, will be expanded for the first time in thre...
Kim Yun-mi
2024-04-24 11:38 AM
-
Pharma
Chong Kun Dang signs licensing deal for Curigin's bladder cancer gene therapy
Chong Kun Dang said it has entered into a licensing agreement with Curigin, a local gene therapy developer, for the latter's CA102, a gene therapy candidate targeting superficial b...
Lee Han-soo
2024-04-24 1:47 PM
-
Hospital
Major hospitals in Seoul to protest government policy with weekly day off
Senior physicians at Seoul National University Hospital (SNUH) and Asan Medical Center (AMC) said they decided to refuse surgery and outpatient care by taking a day off every week ...
Kim Eun-young
2024-04-24 9:51 AM
-
Pharma
Hanmi Pharm partners with MSD for clinical trial of cancer therapy BH3120
Hanmi Pharmaceutical said it has entered into a clinical trial collaboration and supply agreement (CTCSA) with Merck & Co., Inc., known as MSD outside the U.S. and Canada.The partn...
Lee Han-soo
2024-04-23 5:20 PM
-
Bio
Samsung Bioepis gains European approval for Stelara biosimilar
Samsung Bioepis said it has secured final product approval from the European Commission (EC) for its latest biosimilar, Pyzchiva, also known as SB17, a biosimilar candidate referen...
Lee Han-soo
2024-04-23 4:04 PM
-
Device/ICT
Medical AI companies begin to supply homegrown solutions
AI solutions developed by Korean medical artificial intelligence companies, including Lunit, have begun to be used in medical sites, raising expectations among market players and t...
Kim Chan-hyuk
2024-04-23 12:43 PM
-
Policy
Despite government’s refusal to accept resignation, medical professors ‘quietly’...
A top government official recently said that professors at even private medical schools, let alone national ones, are subject to the National Civil Service Act, raising the possibi...
Kwak Sung-sun
2024-04-23 4:02 PM
-
Pharma
GC Biopharma applies for US approval of Sanfilippo Syndrome treatment
GC Biopharma said it has submitted an investigational new drug (IND) application and applied for Fast Track Designation with the U.S. FDA for GC1130A, an intracerebroventricular (I...
Lee Han-soo
2024-04-23 3:02 PM
-
Pharma
Pharos iBio and MEDiC to collaborate on new drug research
Pharos iBio said it has signed a memorandum of understanding with MEDiC Life Sciences, a Silicon Valley-based company that has established a gene-scissor technology (CRISPR) based ...
Yang Hyeon-su
2024-04-23 4:54 PM
-
Pharma
Curocell applies for expedited approval of CAR-T therapy
Curocell, a chimeric antigen receptor-T (CAR-T) developer, has applied for Anbal-cel, its CAR-T candidate, to be included in the Ministry of Food and Drug Safety (MFDS)’s Advanced ...
Lee Han-soo
2024-04-23 11:00 AM
-
Bio
Jung Kwan Jang hosts seminar on red ginseng at US conference
Jung Kwan Jang, Korea’s top ginseng product manufacturer, said it conducted a seminar focused on the efficacy and safety of red ginseng during the International Conference on the S...
Lee Han-soo
2024-04-23 3:02 PM
-
Pharma
Celltrion's Remsima attains 74% market share in 5 key European countries
Celltrion's Remsima (infliximab) line of products continues to demonstrate market impact with expanded prescriptions in five major European countries—the U.K., Germany, France, Spa...
Korea Biomedical Review
2024-04-23 11:51 AM
-
Device/ICT
Kakao Healthcare and OURHOME to research and develop AI-based…
Kakao Healthcare said Tuesday that it has signed a business agreement with global food care and catering company OURHOME to develop AI-based ultra-personalized healthcare solutions...
Korea Biomedical Review
2024-04-23 11:01 AM
-
Pharma
HK inno.N’s GERD drug K-CAB advances to Middle East, North Africa
HK inno.N's GERD drug K-CAB has expanded its momentum to the Middle East and North Africa region.Starting from China and expanding across Asia and North and South America, K-CAB is...
Korea Biomedical Review
2024-04-23 11:50 AM
-
Device/ICT
Deep Bio's prostate cancer diagnosis software aims to enter US…
The importance of early diagnosis of prostate cancer cannot be overstated. According to data from the World Cancer Research Fund International, prostate cancer is the second most c...
Lee Han-soo
2024-04-22 3:13 PM
-
Pharma
MBK Partners to buy pharma distributor Geo-Young for nearly ₩2 trillion: report
Korea's largest private equity firm, MBK Partners, has agreed to purchase a majority stake in Geo-Young, the nation's top pharmaceutical distributor, from Blackstone for approximat...
Lee Han-soo
2024-04-22 4:17 PM
-
Pharma
Palmoplantar pustulosis patients pin hope on Skyrizi’s approval
Skyrizi (risankizumab) has emerged as a new option for treating palmoplantar pustulosis (PPP), a condition characterized by pustules, exfoliation, and red patches on the palms of t...
Kim Chan-hyuk
2024-04-22 4:38 PM
-
Pharma
Bayer Korea launches plogging campaign to celebrate Earth Day
In alignment with Earth Day, an annual event on April 22, Bayer Korea began its annual "Glück for Green" plogging campaign, an initiative designed to foster sustainable practices a...
Lee Han-soo
2024-04-22 5:01 PM
-
Device/ICT
Canon Medical installs AI-backed low-dose radiation CT simulation at Yeungnam...
Canon Medical Systems Korea said it installed Aquilion Exceed LB, a state-of-the-art low-dose radiation CT (computed tomography) simulation machine, at Yeungnam University Medical ...
Korea Biomedical Review
2024-04-22 2:42 PM
-
Device/ICT
Plasmapp to supply plasma sterilizer to Osstem Implant
Plasmapp, a bioplasma deep-tech company, said Monday that it had signed a contract to supply plasma sterilizers to Osstem Implant.Following signing contracts with large global dist...
Korea Biomedical Review
2024-04-22 2:57 PM
-
Device/ICT
Boston Scientific launches intragastric appetite suppression balloon 'BIB System' with coverage
Boston Scientific said Monday that it has released the BIB System, a balloon for suppressing appetite in the stomach that can help obese patients lose weight, with insurance covera...
Korea Biomedical Review
2024-04-22 3:20 PM
-
Hospital
‘Low-dose, off-label prescription of NOACs is a risky, misleading choice’
Atrial fibrillation (AF) is one of the most common arrhythmias, with a higher prevalence in older adults. It significantly increases the risk of stroke, and the number of patients ...
Kim Chan-hyuk
2024-04-22 1:45 PM
-
Pharma
Polycythemia vera moves a step closer to potential cure
Polycythemia vera (PV) is a rare, intractable blood cancer in which a somatic mutation in the bone marrow causes the bone marrow to function abnormally and overproduce red blood ce...
Kim Yun-mi
2024-04-22 1:05 PM
-
Pharma
EuBiologics wins green light for phase 1 trial of shingles vaccine
On Monday, EuBiologics announced that it obtained regulatory approval to initiate a phase 1 study for its proprietary herpes zoster vaccine, EuHZV. With the endorsement from the Mi...
Korea Biomedical Review
2024-04-22 1:31 PM
-
Policy
KPBMA head named to chair Korea's healthcare reform panel
The government has nominated Noh Yun-hong, head of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA), to chair the presidential Special Committee for Health...
Kwak Sung-sun
2024-04-22 11:17 AM
-
Pharma
Regulator approves four generics of oral psoriasis treatment Otezla
Four Korean drugmakers have obtained approval for generic versions of Amgen's oral psoriasis treatment, Otezla (apremilast).Daewoong Pharmaceutical, DongKoo Bio&Pharma, Dong-A ST, ...
Yang Hyeon-su
2024-04-19 4:27 PM
-
Pharma
Pharma distributor Geo-Young's revenue hits ₩4.4 trillion in 2023
Pharmaceutical distribution company Geo-Young said Friday that its consolidated sales for 2023 reached 4.43 trillion won ($3.21 billion).It marked a 5 percent increase from the pre...
Yang Hyeon-su
2024-04-19 4:25 PM
-
Policy
Covid-19 crisis to be downgraded to lowest 'attention' level starting in May
The Covid-19 crisis level will be downgraded to the lowest,“attention,” of the four-tier crisis alert system next month, the government said.The Korea Disease Control and Preventio...
Kwak Sung-sun
2024-04-19 3:27 PM
-
Policy
Seoul accepts university heads’ demand to lower medical school enrollment increase target
Prime Minister Han Duk-soo announced on Friday that the government would accept the request from six national university chiefs to reduce the targeted number of medical school stud...
Kim Yoon-mi
2024-04-19 3:56 PM
-
Device/ICT
Korea approves 2 more DTx for vision improvement, respiratory rehabilitation
The Ministry of Food and Drug Safety has granted approval to two more digital therapeutic (DTx) devices, developed by Nunaps and Share&Service. These devices, which are the third a...
Lee Han-soo
2024-04-19 1:01 PM
-
Hospital
Korean professor named associate editor of European Journal of Preventive Cardiology
Professor Jung Mi-hyang of the Department of Cardiology at the Catholic University of Korea St. Mary's Hospital was recently appointed associate editor of the European Journal of P...
Kim Chan-hyuk
2024-04-19 4:35 PM
-
Pharma
Secretive drug price negotiations on Lorviqua torture patients
The drug price negotiations for Pfizer's third-generation ALK-positive lung cancer drug Lorviqua (lorlatinib) are being done in excessive secrecy, leading to growing frustration am...
Kim Yun-mi
2024-04-19 1:18 PM
-
Pharma
Bridge Biotherapeutics advised to continue P2 study for idiopathic pulmonary fibrosis...
Bridge Biotherapeutics, a Korean biotech firm, announced positive feedback from the third Independent Data Monitoring Committee (IDMC) meeting to continue the phase 2 clinical tria...
Lee Han-soo
2024-04-19 2:01 PM
-
Hospital
Kidney cancer patient group leaders from 21 countries raise awareness and share...
The International Kidney Cancer Coalition (IKCC)’s International Conference 2024 wrapped up its three-day event in Incheon, Korea, on Tuesday. About 60 kidney cancer patient group ...
You Ji-young
2024-04-19 11:12 AM
-
Policy
Nurses may benefit from law that lessens penalties for medical accidents
The government said Thursday that it would consider including nurses as the beneficiaries of the Special Act on Handling Medical Accidents.Officials said there is no problem in inc...
Kwak Sung-sun
2024-04-19 1:08 PM
-
Device/ICT
3Bigs enters distribution agreement with UAE firm
3Bigs, a Korean company specializing in bio big data-based health management solutions, said it entered a distribution partnership with Neo-Science, a bio-health enterprise located...
Lee Han-soo
2024-04-19 11:38 AM
-
Hospital
Government considers expanding treatment options for Korean neuroendocrine tumor...
Koreans with neuroendocrine tumors have been forced to leave for overseas treatment due to the restriction on the number of domestic treatments -- four reimbursed and two non-reimb...
Kim Kyoung-Won
2024-04-18 4:22 PM
-
Policy
Controversy erupts over alleged government hurdles for J-1 visas for Korean trainee...
After some doctors claimed that the government had not issued the Statement of Need for J-1 visas to those planning to train in U.S. hospitals, government officials said such claim...
Kim Ju-yeon
2024-04-18 1:32 PM
-
Pharma
HLB opens new office in Boston's Cambridge Innovation Center to bolster international...
HLB said it opened a new office in the Cambridge Innovation Center (CIC) in Boston, U.S. to bolster the collaboration and communication between HLB and its U.S. subsidiaries, such ...
Lee Han-soo
2024-04-18 4:11 PM
-
Pharma
Hanmi Pharm's novel drug receives INN name 'efpegerglucagon' for treating...
The International Nonproprietary Name (INN) of LAPS Glucagon analog (code name HM15136), which Hanmi Pharm is developing as an innovative new drug for treating congenital hyperinsu...
Yang Hyeon-su
2024-04-18 3:25 PM
-
Bio
SK biopharmaceuticals inks $58 million deal to transfer non-narcotic painkiller tech to...
SK biopharmaceuticals said Thursday it has signed a technology transfer agreement with a Chinese joint venture company, Ignis Therapeutics, for a non-narcotic pain treatment candid...
Kim Chan-hyuk
2024-04-18 3:05 PM
-
Pharma
Handok and Swedish Orphan Biovitrum launch joint venture in Korea
Handok and Swedish Orphan Biovitrum (Sobi) said they have officially inaugurated their Korean joint venture, Handok-Sobi.Sobi is a global biopharmaceutical company specializing in ...
Lee Han-soo
2024-04-18 2:48 PM
-
Pharma
GC Cell’s US affiliate initiates 1st patient dosing for lupus nephritis study
GC Cell said its U.S. affiliate Artiva Biotherapeutics has begun administering the first dose to a participant in a phase 1 clinical trial. This trial investigates the combination ...
Lee Han-soo
2024-04-18 2:04 PM
-
Policy
Keytruda’s coverage expansion effectively ‘shelved’
The Cancer Disease Review Committee (CDRC) of the Health Insurance Review and Assessment Service (HIRA) has once again deferred its decision on expanding coverage for Keytruda (pem...
Kim Yun-mi
2024-04-18 1:55 PM
-
Pharma
Celltrion launches Remsima SC in Denmark
Celltrion said it has been awarded the national tender for the world's only infliximab subcutaneous (SC) formulation, Remsima SC, in Denmark, a key Nordic market. Under the agreeme...
Korea Biomedical Review
2024-04-18 11:18 AM
-
Device/ICT
Coreline Soft begins non-reimbursed billing for AVIEW NeuroCAD brain CT analysis solution
Coreline Soft, a Korean medical AI company, said Thursday that the National Evidence-based Healthcare Collaborating Agency (NECA) has completed “notifying innovative medical techno...
Korea Biomedical Review
2024-04-18 11:03 AM
-
Policy
Why does Korea lag behind Japan and Taiwan in long-term management of Covid-19?
Almost one year has passed since the World Health Organization (WHO) declared the lifting of a Public Health Emergency of International Concern (PHEIC), but is Korea building a lon...
Kim Yun-mi
2024-04-17 11:16 AM
-
Bio
Celltrion announces additional buyback and retirement of its shares
Celltrion announced its decision to further buy back and retire its own shares as part of its ongoing efforts to stabilize its stock price and enhance shareholder value.The company...
Lee Han-soo
2024-04-17 4:08 PM